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It is known that particulate matter (PM) air
pollution is associated with both increased
morbidity and mortality [Brunekreef 1997;
Koenig 2000; Pope 2000; Sunyer 2001; U.S.
Environmental Protection Agency (EPA)
2004]. In many residences, ambient ﬁne par-
ticles readily penetrate indoors (Abt et al.
2000; Allen et al. 2003; Anuszewski et al.
1998; Long et al. 2001; Sarnat et al. 2002),
where most people spend > 90% of their
time. As a result, individuals receive a sub-
stantial fraction of their exposure to ambient-
generated particles while they are indoors.
Therefore, it is important to evaluate the dif-
ferential health effect of particles generated
outdoors from those generated indoors. This
information is needed both for health risk
estimates and regulatory control to protect
public health.
Most health effects studies have tested for
associations between measures of ambient
PM and adverse health effects. Only a few
studies have evaluated the relative toxicity of
indoor versus outdoor PM. One study
assessed the in vitro toxicity of paired indoor
and outdoor PM2.5 (PM with aerodynamic
diameter ≤ 2.5 µm) samples collected in
homes in Boston, Massachusetts (Long et al.
2001). The in vitro test used rat alveolar
macrophages and measured change in tumor
necrosis factor α (TNF-α) as a marker for
inﬂammation. PM2.5 from both outdoor and
indoor samples increased endotoxin-normal-
ized TNF-α levels significantly; however,
the increases were greater for indoor PM sam-
ples (mean, 952 ± 157 pg/endotoxin unit vs.
494 ± 96 pg/endotoxin unit).
Another study evaluated the inﬂuence of
air conditioning on observed associations
between outdoor PM and health outcomes
(Janssen et al. 2002). Health data for hospital
admissions for chronic obstructive pulmonary
disease (COPD) and cardiovascular disease
were obtained for 14 U.S. cities. Home air
conditioning was associated with lower pene-
tration of outdoor particles, and the associa-
tions between PM10 and hospital admissions
were lower in cities with a higher prevalence
of air conditioning.
In a recent panel study of 16 subjects with
COPD in Vancouver, Canada, Ebelt et al. (in
press) developed separate estimates of expo-
sures to ambient and nonambient (i.e., the
sum of indoor-generated particles and particles
generated from personal activities) particles of
different size ranges (PM2.5, PM10–2.5, and
PM10) based on time–activity data and the use
of particle sulfate measurements as a tracer of
ambient particles. Health outcomes were
examined against these estimated exposures.
Total and nonambient particle exposures were
not associated with any of the health out-
comes, whereas estimated ambient exposures
and, to a lesser extent, ambient concentrations
were associated with decreased lung function,
decreased systolic blood pressure, increased
heart rate, and increased supraventricular
ectopic heart beats.
We recently described a technique for
separating personal exposure to PM into its
indoor- and ambient-generated components
using hourly light scattering data and a recur-
sive modeling technique (Allen et al. 2003).
The data came from a large panel study in
Seattle, Washington, that collected indoor, out-
door, and personal exposure data on 107 sub-
jects over a 2-year period (Liu et al. 2003). The
Seattle study also collected various health end
points that included lung function and exhaled
nitric oxide (eNO), a marker of airway inﬂam-
mation, in a subset of children with asthma. In
a previous article we reported eNO associations
with 24-hr PM2.5 concentrations measured
outside the home [4.3 ppb increase in eNO per
10-µg/m3 increase in PM2.5; 95% conﬁdence
interval (CI), 1.4 to 7.2], inside the home
(4.2 ppb; 95% CI, 1.0 to 7.4), and on subjects
(4.5 ppb; 95% CI, 1.0 to 7.9) (Koenig et al.
2003). In this article we describe the results of
analyzing further the health data to test the
associations between health outcomes and esti-
mates of indoor-generated exposure (Eig) and
ambient-generated exposure (Eag) based on
subject time–location data and estimated parti-
cle inﬁltration efﬁciency (Finf; the fraction of
the outdoor concentration that penetrates
indoors and remains suspended). We hypothe-
size that PM2.5 of outdoor origin has more
effect on respiratory outcomes per unit mass
than particles of indoor origin.
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Most particulate matter (PM) health effects studies use outdoor (ambient) PM as a surrogate for
personal exposure. However, people spend most of their time indoors exposed to a combination of
indoor-generated particles and ambient particles that have infiltrated. Thus, it is important to
investigate the differential health effects of indoor- and ambient-generated particles. We combined
our recently adapted recursive model and a predictive model for estimating inﬁltration efﬁciency
to separate personal exposure (E) to PM2.5 (PM with aerodynamic diameter ≤ 2.5 µm) into its
indoor-generated (Eig) and ambient-generated (Eag) components for 19 children with asthma.
We then compared Eig and Eag to changes in exhaled nitric oxide (eNO), a marker of airway
inﬂammation. Based on the recursive model with a sample size of eight children, Eag was margin-
ally associated with increases in eNO [5.6 ppb per 10-µg/m3 increase in PM2.5; 95% conﬁdence
interval (CI), –0.6 to 11.9; p = 0.08]. Eig was not associated with eNO (–0.19 ppb change per
10 µg/m3). Our predictive model allowed us to estimate Eag and Eig for all 19 children. For those
combined estimates, only Eag was signiﬁcantly associated with an increase in eNO (Eag: 5.0 ppb
per 10-µg/m3 increase in PM2.5; 95% CI, 0.3 to 9.7; p = 0.04; Eig: 3.3 ppb per 10-µg/m3 increase
in PM2.5; 95% CI, –1.1 to 7.7; p = 0.15). Effects were seen only in children who were not using
corticosteroid therapy. We conclude that the ambient-generated component of PM2.5 exposure is
consistently associated with increases in eNO and the indoor-generated component is less strongly
associated with eNO. Key words: ambient air pollution, asthma, exhaled nitric oxide, inﬁltration,
PM2.5. Environ Health Perspect 113:499–503 (2005). doi:10.1289/ehp.7511 available via
http://dx.doi.org/ [Online 10 January 2005]
Children’s Health ArticleMaterials and Methods
This study was conducted between winter
2000–2001 and spring 2001 in Seattle,
Washington, as part of a larger exposure assess-
ment and health effect panel study (Liu et al.
2003). Nineteen children, 6–13 years of age,
were recruited from a local asthma and allergy
clinic. All had physician-diagnosed asthma and
were prescribed asthma medications daily or
regularly. Ten of the subjects were not using
inhaled corticosteroid (ICS) medication; nine
were. Each subject in the panel was asked to
participate for a 10-day monitoring session.
Trained technicians made daily home visits to
subjects between 1700 and 2000 hr to take air
and health effect measurements.
Pollutant concentration measurements. PM
measurements were taken inside and outside
of each subject’s residence using the Harvard
impactors for integrated PM2.5 (HI2.5) concen-
trations and using the Radiance nephelometer
(model 903; Radiance Research, Seattle, WA)
at eight residences for continuous light-scatter-
ing measurements. Personal PM2.5 measure-
ments were collected from each subject using
the Harvard personal environmental monitors.
Detailed descriptions and evaluation of these
samplers can be found in Liu et al. (2002). All
integrated measurements were collected over
24 hr (~ 1600 to 1600 hr) for 10 consecutive
days. In addition, NO concentrations were
monitored continuously at the Beacon Hill
central site using a chemiluminescence monitor
operated by the Washington State Department
of Ecology (Olympia, WA).
Measurement of NO. Exhaled breath
measurements were collected offline daily in
the children’s homes into an NO inert and
impermeable Mylar balloon for up to 10 con-
secutive days. Samples were collected in the
afternoon or early evening at the child’s resi-
dence. Children were asked to forgo food
intake for 1 hr before collection of exhaled
breath. Exhaled breath was collected before
lung function measurements, because deep
inspirations affect NO concentration (Deykin
et al. 1998). NO was quantiﬁed within 24 hr
of collection using an API (Advanced Pol-
lution Instrumentation, Inc., San Diego, CA)
chemiluminescent nitrogen oxides (NOx)
monitor (model 200A). We have tested the
stability of NO in the Mylar bags by running
comparisons of values immediately after
collection and at 24 and 48 hr after collection
and found NO values varying by < 2 ppb
(n = 8). A complete description of the meth-
ods has been published (Koenig et al. 2003).
Measurement of lung function. During the
daily visits, coached spirometry values consis-
tent with American Thoracic Society criteria
(American Thoracic Society 1995) were
obtained with MicroDL spirometers (Micro
Medical, Lewiston, ME). Spirometry measure-
ments included forced expiratory volume in
1 sec (FEV1), forced vital capacity (FVC), and
mid-expiratory flow (MEF). In addition,
symptom forms were completed by subjects
and medication use during the previous 24 hr
was reviewed and collected. Subjects also ﬁlled
out a time–location–activity diary (TAD) with
a 15-min resolution.
Estimation of PM exposure components.
We previously described the use of a recursive
mass balance model (RM) to estimate the aver-
age Finf for individual residences (Allen et al.
2003). The RM estimates of Finf agreed well
with those estimated with the sulfur tracer
method (R2 = 0.78; n = 14 residences) (Sarnat
et al. 2002). We also published estimates of Eag
and Eig for PM2.5 among a subset of the Seattle
panel study subjects (Allen et al. 2004). We
estimated the 24-hr average Eag and Eig for each
subject using the RM Finf estimates from the
indoor/outdoor nephelometer measurements,
the indoor (Ci) and outdoor (Co) PM2.5 con-
centrations measured with HI2.5, and the frac-
tion of the day (Fo) that the subjects reported
being outdoors or in transit based on the TAD:
Eag = (Fo)Co + (1 – Fo)(Co × Finf) [1]
Eig = (1 – Fo)[Ci – (Co × Finf)] [2]
Because nephelometer measurements were
only valid at 8 of the 19 subjects’ residences, a
predictive model based on RM Finf estimates
from 62 residences in the Seattle panel study,
residence type, outdoor temperature, average
daily rainfall, and the use of air cleaners was
constructed to estimate Finf in the remaining
11 homes (Table 1). The estimated Finf values
from the predictive model were compared
against those from the RM and validated
against the conventional sulfur method (Allen
et al. 2003), which uses the regression slope of
indoor versus outdoor sulfur concentrations for
each residence as the estimated Finf. As a result
of calculating Finf using both the RM and the
predictive model, three groups of Eag and Eig
estimates were created: a) those using the RM
Finf values (n = 8 unique subjects), b) those
using the predictive model Finf values (n = 11
unique subjects), and c) a combination of the
above two—that is, RM Finf values when avail-
able and the predictive model Finf for the
remaining subjects (henceforth called the com-
bined model; n = 8 + 11 = 19 subjects).
Statistical analysis. We used a linear mixed
effects model with random intercept to test for
within-subject associations between eNO and
various PM2.5 exposure estimates. The model
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Table 1. Results of regression analysis for Finf (n = 62 residences).
Parameter Estimate SE 95% CI p-Value
Intercept 0.41 0.07 0.28 to 0.54 < 0.001
Residence type
Private home (reference)
Private apartment 0.03 0.05 –0.08 to 0.14 0.61
Group home 0.19 0.06 0.07 to 0.31 < 0.01
Air cleaner
None (reference)
Ion generator –0.07 0.05 –0.16 to 0.02 0.14
Filter –0.08 0.07 –0.22 to 0.05 0.23
Electrostatic precipitator –0.11 0.06 –0.22 to 0.00 0.05
Average outdoor temperature (°C)a
< 4 (reference)
4–8 0.19 0.07 0.06 to 0.32 < 0.01
8–12 0.32 0.07 0.18 to 0.45 < 0.001
≥ 12 0.45 0.07 0.31 to 0.58 < 0.001
Average daily rainfall (inches)b
< 0.5 (reference)
0.05–0.1 –0.07 0.05 –0.16 to 0.02 0.13
> 0.1 –0.15 0.06 –0.26 to –0.04 < 0.01
The regression coefﬁcients are used to predict Finf in residences without nephelometer data (“predictive model”).
aAt Beacon Hill Central Site. bAt Sand Point Way National Weather Service station.
Table 2. Distributions of residential indoor and outdoor concentrations and personal Eig and Eag (µg/m3).
Total no. of
monitoring No.
Model Concentration eventsa (days) Mean Minimum 25% Median 75% Maximum
Home indoor 27 (19) 248 9.5 2.3 5.7 7.6 10.8 36.3
Home outdoor 11.1 2.8 6.3 9.5 14.6 40.4
Recursive Eag 11 (8) 101 7.0 1.8 4.2 5.9 9.2 22.6
Eig 2.1 0.0 0.0 1.2 2.3 17.2
Predictive Eag 16 (13) 147 6.0 1.3 3.4 5.0 7.5 22.6
Eig 4.0 0.0 0.9 2.2 4.9 33.0
Combined Eag 27 (19) 248 6.4 1.3 3.7 5.5 7.8 22.6
Eig 3.2 0.0 0.5 1.7 4.2 33.0
Abbreviations: 25%, 25th percentile; 75%, 75th percentile.
aNumber of unique subjects in parentheses.included an interaction term between medica-
tion use and PM, a term for the within-subject,
within-session (10-day monitoring period)
effects, and a term for the subject between-
session effects. We adjusted for the confound-
ing variables of temperature, relative humidity,
and, in the model for eNO, ambient NO meas-
ured at the Beacon Hill site. We also adjusted
for subject age and body mass index (BMI).
Our primary interest was the within-subject
and within-session effect of PM. Analyses were
conducted with all children from both winter
and spring sessions. STATA 7.0 (Stata Corp.,
College Station, TX) was used for all health
analyses, and SAS statistical package (version
8.0; SAS Institute, Cary, NC) using PROC
Genmod with a repeated statement was used
for the predictive model Finf modeling. All
three Eag/Eig data sets (recursive, predictive,
and combined) were examined with a focus on
the combined data set.
The model used for the eNO analysis was
as follows:
E[Y] = B0 + bi + B1(Xids – X
–
is) + B2(X
–
is – X
–
i) 
+ B3X
–
i + B4medi + B5medi
× (Xids – X
–
is) + B6(Zids – Z
–
is)
+ B7(Z
–
is – Z
–
i) + B8Z
–
i + B9Age
+ B10BMI + B11Temp + B12RH, [3]
where RH is relative humidity and BMI is
body mass index. This basic model was used
previously in the original analysis of the rela-
tionship between eNO and PM in the children
with asthma (Koenig et al. 2003), where Xids is
the PM2.5 reading for individual i on day d
during session s, X
–
is is the mean PM2.5 reading
for a subject during a session, X
–
i is the mean
PM2.5 reading for a subject during one or two
sessions, medi is an indicator for medication
use (constant for each subject ), Zids is the
ambient NO reading for individual i on day d
during session s, Z
–
is is the mean ambient NO
reading for a subject during a session, and Z
–
i is
the mean ambient NO reading for a subject
during all sessions.
We also analyzed the data using general-
ized estimating equations (GEE) with an
exchangeable working correlation matrix and
robust SEs to adjust for autocorrelation in the
data. The GEE model produced similar effect
estimates.
Results
Nineteen children with asthma participated in
this panel study in Seattle. All subjects com-
pleted one 10-day monitoring session, and
10 subjects completed two sessions. During this
study, the home indoor and outdoor PM2.5
concentrations averaged 9.5 and 11.1 µg/m3,
respectively (Table 2), whereas personal expo-
sure to total PM2.5 averaged 13.4 µg/m3. The
total personal PM2.5 exposure was then sepa-
rated into indoor- and outdoor-originated com-
ponents using the RM for eight residences with
nephelometer measurements and a predictive
model for the remaining 11 residences. The
predictive model for Finf employed two impor-
tant home characteristics, residence type, and
the use of air cleaner, as well as outdoor temper-
ature and precipitation as surrogates for changes
of home ventilation conditions (Table 1). This
predictive model agreed well with the RM
(R2 = 0.60) and the sulfur tracer Finf estimates
(R2 = 0.66) (Figure 1). The average Finf for the
19 subjects was 0.56 ± 0.15 (range, 0.23–0.86).
The average Eag and Eig from the RM model
were not signiﬁcantly different from those esti-
mated from the predictive model (Table 2).
Thus, we pooled the Eag and Eig estimates
from both models for the following health
effect assessment. We examined the Eag and
Eig estimates from the combined model for
their associations with increase in eNO.
Table 3 shows distributions for the health end
points. In this analysis we found that eNO
was associated with Eag estimated among
subjects not on prescribed ICS medication
(5.0 ppb per 10-µg/m3 increase in estimated
exposure; 95% CI, 0.3 to 9.7; Table 4). There
was no association between eNO and Eig
(Table 4). In contrast to our findings with
eNO, associations between changes in lung
function and estimated exposures were found
for Eig but not for Eag. Furthermore, the
results were not statistically signiﬁcant across
all lung function measures. FEV1 and FVC
were both significantly negatively associated
with Eig in children not using ICS (FEV1, p =
0.01; FVC, p = 0.00), whereas MEF was nega-
tively, but not signiﬁcantly, associated with Eig
(p = 0.35). No significant associations were
seen between lung function changes and the
combined model estimates of Eag.
Table 5 shows associations between
the eNO and measured PM2.5 on subjects
(Harvard personal environmental monitor)
and at home indoors and outdoors in the same
19 children included in the combined model.
As shown in Table 5, associations were found
between eNO and measured outdoor, indoor,
and personal PM2.5 (p = 0.01–0.03). In all
Children’s Health | Effects of indoor- and outdoor-generated particles
Environmental Health Perspectives • VOLUME 113 | NUMBER 4 | April 2005 501
Figure 1. Comparisons between predictive model Finf
estimates and the Finf estimates obtained using the
recursive model (A; n = 62; y = 0.59x + 0.26; R2 = 0.60)
and the sulfur tracer technique (B; n = 25; y = 0.61x +
0.25; R2 = 0.66).
0.0 0.2 0.4 0.6 0.8 1.0
1.0
0.8
0.6
0.4
0.2
0.0
0.0 0.2 0.4 0.6 0.8 1.0
1.0
0.8
0.6
0.4
0.2
0.0
P
r
e
d
i
c
t
i
v
e
 
m
o
d
e
l
  F
i
n
f
P
r
e
d
i
c
t
i
v
e
 
m
o
d
e
l
  F
i
n
f
Recursive model Finf
Sulfur tracer Finf
A
B
Table 3. Descriptive statistics of health outcomes.
Health No. of subjects Person-
measurement (no. sessions) days Mean Minimum 25% Median 75% Maximum
eNO (ppb) 19 (29) 240 15.4 5 9.7 12.5 18.0 79.8
FEV1 (L) 17 (29) 269 1.8 0.5 1.4 1.9 2.2 3.4
MEF (L/min) 17 (29) 269 113 21 71 107 149 320
FVC (L) 17 (29) 269 2.3 0.7 1.9 2.4 2.7 3.5
Abbreviations: 25%, 25th percentile; 75%, 75th percentile. 
Table 4. Associations between eNO (ppb) and outdoor- versus indoor-generated particles in children with
asthma: recursive model (n = 8), predictive model (n = 11), and combined model (n = 19).
Use of Change per 10 µg/m3
Exposure Model medication estimated PM2.5 95% CI p-Value
Eig Combined No 3.29 –1.14 to 7.73 0.15
Yes –4.94 –10.94 to 1.06 0.11
Eag Combined No 4.98 0.28 to 9.69 0.04
Yes 1.67 –3.77 to 7.12 0.55
Eig Recursive No –0.19 –8.37 to 8.00 0.97
Yes –0.47 12.03 to 11.10 0.94
Eag Recursive No 5.63 –0.62 to 11.88 0.08
Yes –4.30 –14.60 to 6.01 0.41
Eig Predictive No 3.46 –0.90 to 7.83 0.12
Yes –4.99 –11.01 to 1.04 0.11
Eag Predictive No 5.33 0.31 to 10.35 0.04
Yes 1.66 –3.75 to 7.06 0.55cases, the changes were seen only in children
not using ICS medications.
Discussion
Our study has shown that, for eNO, ambient-
generated particles are more potent per unit
mass than indoor-generated particles. This Eag
effect on eNO using the combined model esti-
mates also agreed well with the estimates from
both the RM and the predictive model. The
increases in eNO associated with Eag were
5.6 ppb for the RM estimates (p = 0.08),
5.3 ppb for the predictive model estimates
(p = 0.04), and 5.0 ppb for the combined
model (p = 0.04). Corresponding changes
with Eig were not signiﬁcant (p = 0.41, 0.12,
and 0.15, respectively). In this respect, our
results agree with those of Ebelt et al. (in
press), who found that outdoor-generated par-
ticles were associated with health outcomes,
whereas nonambient particles were not in a
group of subjects with COPD in Vancouver.
These two studies demonstrate the usefulness
of separating total personal particle exposures
into indoor- and outdoor-generated compo-
nents and the relative potency of indoor- and
outdoor-generated particles.
Our conclusion that eNO is associated
more strongly with outdoor-generated particles
than indoor-generated particles is supported by
the internal consistency of the results. For sub-
jects with combined model estimates of Finf,
the estimated increase in eNO per 10-µg/m3
increase in PM2.5 was 5.0 ppb (p < 0.04) for
Eag, which was greater than the 3.9 ppb for
outdoor measured PM2.5 (p = 0.01) because
Eag takes into account personal activities and
particle infiltration efficiency to arrive at a
more accurate estimate of exposure to ambient-
originated PM (Table 5). The effect of meas-
ured total indoor PM2.5, a combination of
indoor- and outdoor-generated particles, on
eNO was 4.1 ppb/10 µg/m3 PM2.5 (p = 0.01)
in Table 5, which was reduced to a nonsigniﬁ-
cant 3.3 ppb/10 µg/m3 PM2.5 (p = 0.15) for
Eig when the ambient PM contribution was
removed from the total exposures. In all three
exposure models, Eag was more strongly associ-
ated with eNO than was Eig. Also, Eag showed
an interaction with ICS use, as did our original
study with outdoor, indoor, and personal meas-
ured PM2.5 (Koenig et al. 2003).
Our lung function results show that expo-
sure to particles generated indoors, but not
outdoors, was associated with decrements of
lung functions except for MEF. Furthermore,
the association was not consistent across all
three exposure models. Both combined
(n = 17 subjects) and predictive models (n = 9
subjects) showed similar results for FEV1 and
FVC, whereas the recursive model estimates
for eight subjects showed nonsigniﬁcant asso-
ciation between these lung function measures
and Eig. The fact that some lung function
decrements were associated with indoor-gener-
ated particles indicates that the relationship
between respiratory health and PM is com-
plex. It was not surprising that the PM2.5 asso-
ciations with eNO and lung function were not
consistent. This disagreement between eNO
increases and lung function changes has been
reported in clinical literature that consistently
shows either no correlation or a negative cor-
relation between changes in eNO and changes
in FEV1 among subjects with asthma (Dal
Negro et al. 2003; Li et al. 2003; Nightingale
et al. 1999; Steerenberg et al. 2003).
Outdoor particle concentrations are associ-
ated with a wide spectrum of respiratory health
effects including respiratory symptoms in chil-
dren with asthma (Delﬁno et al. 1998), lung
function decrements in children with asthma
(Delﬁno et al. 2002; Koenig et al. 1993), hos-
pital admissions in the general population
(Schwartz 1996; Sheppard et al. 1999), and
mortality in the general population (Dockery
et al. 1993; Schwartz 2000). On the other
hand, there are also studies showing adverse
respiratory health effects associated with
indoor-generated particles including allergens,
dust mites, fungal spores, endotoxins, and
viruses (Long et al. 2001; Majid and Kammen
2001; Simoni et al. 2002; Smedbold et al.
2002; Wan and Li 1999).
Our results for eNO appear to be biologi-
cally plausible because asthma is an inﬂamma-
tory disease and perturbations in asthma are
expected to be associated with markers of air-
way inﬂammation. Several studies show rela-
tionships between eNO and outdoor exposure
to PM or other air pollutants. One study found
an association between exhaled NO values
and high levels of outdoor carbon monoxide
and NO, but not PM, in the Netherlands in
healthy nonsmoking subjects (van Amsterdam
et al. 1999, 2000). More recently, eNO levels
were associated with exposure to PM10, black
smoke, nitrogen dioxide, and ambient NO in a
panel study of children in the Netherlands
(Steerenberg et al. 2001) and in a panel of
adults with respiratory disease (Jansen et al.
2004). Adamkiewicz et al. (2004) presented
data showing an association between measures
of air pollution and eNO values in a panel of
elderly nonsmoking subjects with cardiac dis-
ease in Steubenville, Ohio (USA). Their analy-
sis found a 1.5-ppb increase in eNO (95% CI,
0.3 to 2.6) for a mean interquartile range
increase in PM2.5.
Model limitations. It is challenging to
model personal exposure among children
partly because of the elevated personal cloud
and children’s movement between several
indoor microenvironments (Liu et al. 2003;
Wu et al. in press). Children in the Seattle
panel study spent an average of 66% of their
time indoors at home and 21% indoors away
from home (primarily at school), whereas
the adults in the larger panel study in Seattle
spent an average of 83–88% of their time
indoors at home (Liu et al. 2003). Because we
only collected stationary indoor measure-
ments and estimated Finf in the subjects’ resi-
dences, we made a strong assumption that all
indoor environments encountered by the sub-
ject were represented by their residence. This
assumption may have resulted in uncertainties
in the exposure estimates because of the con-
siderable fraction of time that this group
spent in unmonitored indoor environments,
especially school.
To make the most efﬁcient use of our eNO
and spirometry data, we developed a predictive
model to estimate Finf (and therefore Eag and
Eig) in residences for which nephelometer data
were not available (Table 1). Although the pre-
dicted Finf estimates were validated with an
independent estimate of Finf (Figure 1), the
predictive model is derived from the estimates
produced by the recursive model, and as a
result the predictive model estimates include
errors introduced by a two-step modeling pro-
cedure. Nevertheless, the consistency of the
associations between Eag and eNO for the RM
and the combined model exposure estimates
provides evidence of the reliability of the com-
bined model’s Finf estimates.
Conclusion
Our eNO results support our hypothesis that
PM2.5 of outdoor origin could be more potent
per unit mass than particles of indoor origin.
However, our lung function data indicate that
PM2.5 of indoor origin might be more potent
per unit mass in resulting in decrements of
lung functions, although the results across
functional tests were not consistent. If outdoor
particles are more strongly associated with
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Table 5. Results of eNO analyses with indoor, outdoor, and personal monitors for 19 children included in
the combined model.
Use of Change per 10 µg/m3
Measure medication estimated PM2.5 95% CI p-Value
Personala No 4.48 0.95 to 8.00 0.01
Yes –0.49 –2.95 to 1.98 0.70
Outdoor No 3.90 0.91 to 6.88 0.01
Yes 1.00 –2.10 to 4.09 0.53
Indoor No 4.13 0.87 to 7.38 0.01
Yes –1.37 –5.44 to 2.70 0.51
aTwo sessions removed from personal PM analysis because of insufﬁcient data.Children’s Health | Effects of indoor- and outdoor-generated particles
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adverse health outcomes than particles gener-
ated indoors, the fact that outdoor particles
readily penetrate indoors would partially
explain why epidemiologic time series studies
consistently ﬁnd associations between health
outcomes and PM measured at outdoor ﬁxed
sites despite the fact that people spend most of
their time indoors.
This is a preliminary study using a newly
developed exposure source model that we hope
will be useful to air pollution epidemiology. We
tentatively conclude that partitioning personal
exposure into indoor- versus outdoor-generated
particles is useful in understanding the health
effects of sources of personal PM2.5 and that the
effects of indoor- versus outdoor-generated par-
ticles differ for different health end points.
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